APMD

Apnimed, Inc.

Healthcare · Biotechnology

21.90$ -8.3% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Income Statement

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement APMD
Line item	Q1 25	Q2 25	Q1 26	Q2 26
Revenue	–	–	2.13	0.30
Cost of Revenue	–	–	0.05	0.03
Gross Profit	–	–	2.08	0.27
Research & Development	–	–	0.20	0.25
Selling, General & Administrative	–	–	0.16	0.32
Total Operating Expenses	–	–	0.42	0.60
Operating Income	–	–	1.71	-0.29
Pre-Tax Income	–	–	1.77	3.17
Net Income	–	–	1.77	3.16

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.